Portfolio company
Immuneed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides ex vivo whole blood analysis services to pharmaceutical and biotechnology companies for preclinical drug safety and function assessment.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ImmuneSpec
This company provides immunopeptidomics analysis services to biotechnology and pharmaceutical firms to support vaccine development, immunotherapy research and biotherapeutic immunogenicity risk assessment.
RoukenBio
This company provides immunology and bioassay research services for biopharmaceutical firms to support drug discovery and preclinical development.
Immunitrack
This company provides epitope screening platforms and reagents to pharmaceutical and biotechnology organisations to predict and monitor immune responses during drug development.
AnaBios
This company provides human tissue samples and functional assays to pharmaceutical firms and academic researchers to support preclinical drug discovery and safety testing.
Meadowhawk Biolabs
This company provides preclinical research services, including bioanalysis and pharmacology studies, to biotechnology and pharmaceutical firms to support drug discovery and development.
bioseek
This company provides primary human cell-based disease models and drug discovery services for pharmaceutical and biotechnology organisations.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
Immulus
The company develops manufacturing processes to selectively expand T-cells for drug development for pharmaceutical and biotechnology customers.
